google ads
Chest: Svc Imaging Pearls - Educational Tools | CT Scanning | CT Imaging | CT Scan Protocols - CTisus
Imaging Pearls ❯ Chest ❯ SVC

-- OR --

  • SVCS is a combination of signs and symptoms that result from the compression or occlusion of the superior vena cava, associated with a significant morbidity and mortality. While thoracic malignancy is the most common cause of SVCS accounting for more than 60% of the cases, benign causes are on the rise with the increasing use of central venous catheters and indwelling cardiac devices .Benign SVCS usually has a more insidious course compared to malignant causes, as there is time for the development of adequate collaterals to bypass the central venous occlusion.
    Superior vena cava syndrome with the hepatic ‘hot spot’ sign.  
    Koratala, A., Bhatti, V.  
    Intern Emerg Med 13, 293–294 (2018).
  • A CT scan of the chest with contrast excluded acute pulmonary embolism, but showed extensive chest wall venous collaterals with near-complete occlusion of the superior vena cava. In addition, it demonstrated the “focal hepatic hot spot sign,” which is an enhanced area in the segment IV or quadrate lobe of the liver, which results from the communication between superficial epigastric veins and left portal vein in cases of superior vena cava obstruction
    Superior vena cava syndrome with the hepatic ‘hot spot’ sign.  
    Koratala, A., Bhatti, V.  
    Intern Emerg Med 13, 293–294 (2018).
  • OBJECTIVE. The purpose of this article is to review the CT findings associated with superior  vena  cava  obstruction  and  to  illustrate  collateral  venous  pathways  bypassing  the  ob-struction as shown on MDCT.
    CONCLUSION. Multiple collateral venous pathways can form to bypass an obstruction of the superior vena cava. With its ability to acquire near isotropic data, MDCT allows high-quality reformations and thus exquisitely displays these venous collaterals and has the potential to aid in planning therapy to bypass the obstruction.    
    Superior Vena Cava Obstruction Evaluation With MDCT              
    Sheila Sheth, Mark D. Ebert, and Elliot K. Fishman              
    American Journal of Roentgenology 2010 194:4, W336-W346
  • “Obstruction  of  the  superior  vena  cava  re-sults  in  impaired  venous  drainage  of  the head  and  neck  and  upper  extremities.  Clinical  manifestations  include  facial  and  neck swelling, distended neck veins, headache due to  cerebral  edema,  dyspnea,  and,  in  severe cases, stridor and altered mental status. Cor-relation of imaging studies with clinical find-ings  suggests  that  the  severity  of  symptoms depends on the level of obstruction (above or below  the  level  of  the  azygos  arch)  and  the development of rich collateral network. In fact, CT can detect subclinical superior vena cava obstruction in patients who are relatively asymptomatic.”        
    Superior Vena Cava Obstruction Evaluation With MDCT              
    Sheila Sheth, Mark D. Ebert, and Elliot K. Fishman              
    American Journal of Roentgenology 2010 194:4, W336-W346
  • “The  radiologist  should  be  familiar  with findings  on  abdominal  CT  that  suggest  the presence  of  a  superior  vena  cava  obstruc-tion. In addition to enhancing round or tortu-ous vascular channels in the abdominal wall,  perfusion  abnormalities  in  the  liv-er  and  the  so-called  “hot  spot”  initially  de-scribed on nuclear medicine both result from communication  between  superficial  epigas-tric veins and left portal vein. On CT, there is intense opacification of the anterior quadrate  lobe.  The  area  of  enhancement  is  characteristic  in  its  position  as  well  as  its  shape and  should  not  be  mistaken  for  a  hypervascular mass.”
    Superior Vena Cava Obstruction Evaluation With MDCT
    Sheila Sheth, Mark D. Ebert, Elliot K. Fishman
    AJR 2010; 19 4:336–346 
  • “Fibrosing mediastinitis  is  a  rare  histologically  benign  disorder caused by proliferation of collagen tissue  and  fibrosis  in  the  mediastinum.  It  may be idiopathic, caused by an abnormal immunologic response to Histoplasma capsulatum infection or to tuberculosis, or it may be related  to  retroperitoneal  fibrosis,  particularly in its diffuse form. Radiation-induced fibro-sis is another potential cause of superior vena cava obstruction.”
    Superior Vena Cava Obstruction Evaluation With MDCT
    Sheila Sheth, Mark D. Ebert, Elliot K. Fishman
    AJR 2010; 19 4:336–346 
  • “The incidence of catheter-induced supe-rior vena cava obstruction is rapidly increasing. Large  central  venous  catheters,  such  as  dialysis catheters, Hickman catheters, and parenter-al nutrition catheters, have all been implicated in superior vena cava obstruction. Transvenous permanent  cardiac  pacemaker  implantation  is another  risk  factor,  particularly  after  an  atrio-ventricular node ablation procedure.”
    Superior Vena Cava Obstruction Evaluation With MDCT
    Sheila Sheth, Mark D. Ebert, Elliot K. Fishman
    AJR 2010; 19 4:336–346 
  • “The  azygos  and  hemiazygos veins  can  divert  blood  away  from  the  superior  vena  cava.  If  the  level  of  superior  vena cava  obstruction  is  above  the  azygos  arch, antegrade  flow  from  the  azygos  to  the  right atrium  is  seen,  with  abrupt  transition  between  a  densely  opacified  azygos  above  the arch and an unopacified inferior azygos vein. If  the  obstruction  is  below  the  arch,  the  entire azygos and hemiazygos veins are bright-ly  opacified  as  the  blood  flows  in  a  retro-grade  fashion  toward  the  inferior  vena  cava .”
    Superior Vena Cava Obstruction Evaluation With MDCT
    Sheila Sheth, Mark D. Ebert, Elliot K. Fishman
    AJR 2010; 19 4:336–346 
  • In their study, Rehan et al.  presented a comparative analysis between two computed tomography (CT)-based techniques used in the frame of CT pulmonary angiography (CTPA), the gold standard for imaging diagnosis of pulmonary embolism (PE). These authors have developed a modified CTPA technique using high-pitched CT image acquisition, coupled with the application of tin (Sn) filtration (HPTF) that was aimed to achieve reduction of the effective radiation dose delivered to young (and pregnant) females with suspected PE. When compared to conventional CTPA, the high-pitched tin pre-filtered technique yielded significant radiation dose reduction with no degradation of CT image quality
    MIP technique on CTPA may be helpful in diagnosing pulmonary embolism
    Daphne J. Theodorou · Stavroula J. Theodorou · Ekaterini Ahnoula
    Emergency Radiology (2023) 30:697–699
  • We have been regularly using maximum- intensity projection (MIP) images generated from the original high resolution CT data for improved depiction of intraluminal thrombi. The MIP technique used for CT angiography allows for optimized vessel-to-background contrast and permits detection of hypodense structures (thrombi) in a specific volume after intravascular contrast administration .Because the MIP technique may suppress the anatomic background (lung parenchyma) and display even the small contrast-enhanced vessels, we have noted that in some instances, MIP images may reveal small thrombi that are not conspicuous on the initial thin-section CT images. In our emergency radiology practices, we have realized that MIP images in the coronal plane have proved most useful in the detection of PE, providing additional global assessmentof the entire pulmonary artery vasculature. This observation may indeed help practicing radiologists diagnose PE, especially in ambiguous clinical cases.
    MIP technique on CTPA may be helpful in diagnosing pulmonary embolism
    Daphne J. Theodorou · Stavroula J. Theodorou · Ekaterini Ahnoula
    Emergency Radiology (2023) 30:697–699
  • Pulmonary Artery Aneurysm: Causes
    • Congenital (50%)
    • In general, it is presumed that increased flow caused by left-to-right shunt results in increased hemodynamic shear stress on the vessel walls and therefore promotes aneurysm formation in the PAs.The 3 most frequent congenital heart defects associated with a PAA are, in decreasing order, persistent ductus arteriosus, ventricular septal defects, and atrial septal defects.
  • Pulmonary Artery Aneurysm: Causes
    • Congenital (50%)
    • Pulmonary valve stenosis
    • Ehlers-Danlos syndrome
    • Marfan syndrome
    • Cystic medial necrosis
    • Untreated syphilis and tuberculosis
    • IVDA
    • Vasculitis (Behcet Syndrome) 
  • “In general, clinical manifestations of PAA remain nonspecific, whereas most patients with a PAA, even those with large PAA diameters up to 70 mm, have no complaints.Clinical symptoms include dyspnea, chest pain, hoarseness, palpitation, and syncopal episodes. Bronchus compression by a large PAA may be responsible for cyanosis, cough, and increasing dyspnea, pneumonia, fever, and bronchiectasis. In addition, patients with PAA have a high incidence of pulmonary emboli.”


    Aneurysms of the Pulmonary Artery
Maximilian Kreibich et al.
 Circulation. 2015;131:310-316 

  • “Overall, surgery remains the cornerstone of therapy for lesions involving the main pulmonary trunk, and evidence suggesting an absolute diameter threshold for surgery of the main PA is lacking. However, from our clinical experience and scientific knowledge of all the available data about aortic aneurysms, we suggest operating on adults with pulmonary trunk aneurysms >5.5 cm according to the guidelines for aortic disease.”


    Aneurysms of the Pulmonary Artery
Maximilian Kreibich et al.
 Circulation. 2015;131:310-316 

  • “In case of conservative treatment, it is our opinion that patients should be re-evaluated regularly, and a change in treatment should strongly be considered in case of compression of adjacent structures, thrombus formation in the aneurysm sack, ≥5-mm increase in the diameter of the aneurysm in 6 months, the appearance of clinical symptoms, evidence of valvular pathologies or shunt flow, and verification of PAH.”


    Aneurysms of the Pulmonary Artery
Maximilian Kreibich et al.
 Circulation. 2015;131:310-316 

  • “The largest meta-analysis to date exam- ined over 10,000 patients up to the year 2009 and reported incidental PE had a prevalence of 2.6% (95% CI, 1.9–3.4%), with a higher prevalence in patients with VTE risk factors such as malignancy (3.1%) and inpatient status (4.0%).”

    
Management of the Incidental Pulmonary Embolism 
Victor Chiu, Casey O’Connell 
AJR 2017; 208:485–488 

  • “Although treatment of symptomatic PE with anticoagulation results in a clear reduction in mortality, the bene ts of treating incidental PE have not yet been evaluated in a large prospective study. The risk of major bleeding while on anticoagulation for any VTE is 7.2 per 100 patient-years, making the decision to treat one of great consequence, particularly in higher risk patients such as those in the ICU and those with cancer.”


    Management of the Incidental Pulmonary Embolism 
Victor Chiu, Casey O’Connell 
AJR 2017; 208:485–488 

  • “The National Comprehensive Cancer Network also recommends treatment of incidental PE similar to that for symptomatic PE in patients with cancer and recommends against routinely obtaining repeat imaging.”

    
Management of the Incidental Pulmonary Embolism 
Victor Chiu, Casey O’Connell 
AJR 2017; 208:485–488 

  • “Pulmonary CTA is well established as a fast and reliable means of excluding or diagnosing PE. Continued developments in CT system hardware and postprocessing techniques will allow incremental reductions in radiation and contrast material requirements while improving image quality. Advances in risk strati cation and prognostication from pulmonary CTA examinations should further re ne its clinical value while minimizing the potential harm from overutilization and overdiagnosis."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “This technique is effective despite the variable embrace by clinicians of the d-dimer test, a test that suffers from low specificity. However, the advantage of this laboratory marker lies in its high negative predictive value, so that acute PE can be safely excluded by a negative d-dimer result. In case of elevated d-dimer values, pulmonary CTA should be performed."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “For example, pulmonary CTA has emerged as a formidable prognostic marker to gauge the 
severity of hemodynamic compromise from acute PE and identify patients at heightened risk for fatal or nonfatal adverse events, thus guiding clinical management toward more aggressive therapy. The main methods that have been described to categorize the hemodynamic relevance and severity of PE are imaging markers of right heart strain, methods for clot burden quantification, and lung perfusion measurements."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “For clinical purposes, across all endpoints, the right ventricle (RV) diameter–left ventricle (LV) diameter ratio on pulmonary CTA has the strongest predictive value and most robust evidence base for adverse clin- ical outcomes in patients with acute PE. A ratio of more than 1 on traverse images and of more than 0.9 using true four-chamber view reconstructions is considered indicative of right heart strain and has been shown to predict adverse outcomes and early death."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “One study investigating spectral optimization in monochromatic dual-energy pulmonary CTA with reduced iodine load suggested that 60 keV may be the optimal energy level to analyze the thoracic circulation . Other investigators have also concluded that iodine load can be reduced when virtual monoenergetic images extrapolated to photon energies of 50 or 70 keV are used ."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “Pulmonary CTA is well established as a fast and reliable means of excluding or diagnosing PE. Continued developments in CT system hardware and postprocessing techniques will allow incremental reductions in radiation and contrast material requirements while improving image quality. Advances in risk stratification and prognostication from pulmonary CTA examinations should further refine its clinical value while minimizing the potential harm from overutilization and overdiagnosis."


    State-of-the-Art Pulmonary CT Angiography for Acute Pulmonary Embolism 
Moritz H. Albrecht et al.
 AJR 2017; 208:495–504
  • “In this rare vascular developmental anomaly, the left pulmonary artery arises from the posterior aspect of the right pulmonary artery and passes between the trachea and esophagus to reach the left hilum. The left pulmonary artery thus forms a sling around the distal trachea and the proximal right main bronchus.”


    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • “Those affected by pulmonary artery sling may be classified generally into two groups: one with a normal bronchial pattern and the other with one or more malformations of the bronchotracheal tree (eg, stenosis of a long segment of the trachea or absence of the pars membranacea) as well as cardiovascular abnormalities. In the latter group, mortality and morbidity are high during infancy.The former group includes very few asymptomatic adults. In asymptomatic cases, a pulmonary artery sling may mimic a mediastinal mass on chest radiographs . CT and magnetic resonance (MR) imaging may be used to establish the diagnosis with certainty.”


    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • “Idiopathic dilatation of the pulmonary trunk is a rare congenital anomaly that involves abnormal enlargement of the pulmonary trunk, with or without dilatation of the right and left pulmonary arteries . To reach this diagnosis, it is necessary to exclude pulmonary and cardiac diseases (mainly pulmonary valve stenosis) and to confirm the presence of normal pressure in the right ventricle and pulmonary artery .”

    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • “Aneurysms or pseudoaneurysms of the pulmonary arteries, whether congenital or acquired, are rare. They may occur in association with a congenital cardiovascular anomaly, especially patent ductus arteriosus; infection (mycotic aneurysm); trauma, most commonly as a result of pulmonary artery perforation (due to improper placement of a catheter) or penetrating injury and very rarely as a result of blunt injury; vascular abnormality (eg, cystic medial necrosis, Behçet disease, Marfan syndrome, and Takayasu disease); and pulmonary hypertension.”

    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • “Most mycotic aneurysms are secondary to endovascular seeding due to septic pulmonary emboli and are found in patients with endocarditis. Aneurysms secondary to a direct extension of infection from the adjacent parenchyma are seen in patients with necrotizing pneumonia or chronic tuberculosis. Mycotic aneurysms can be single or multiple and can be located centrally or peripherally.”

    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • “Rasmussen aneurysm is a rare condition caused by weakening of the pulmonary artery wall from adjacent cavitary tuberculosis. Hemoptysis is the usual symptom at initial manifestation. Although the source of hemoptysis in cavitary tuberculosis is usually the bronchial arteries, Rasmussen aneurysm usually occurs in a peripheral pulmonary artery (. Chest radiographic findings that may suggest the formation of a pseudoaneurysm include an intracavitary protrusion, the replacement of a cavity by a nodule, or a rapidly growing mass.”

    Congenital and Acquired Pulmonary Artery Anomalies in the Adult: Radiologic Overview
Castañer E et al.
RadioGraphics 2006 26:2, 349-371
  • SVC Syndrome: Facts
    - Malignancies responsible for SVC syndrome in 78-97% of cases
    - Lung cancer and lymphoma are most common cause of SVC syndrome
    - Other causes of SVC syndrome include metastatic adenopathy (i.e. breast cancer). Germ cell tumors, thymoma
  • SVC Obstruction: Facts
    - Lung cancer is most common cause
    - Collaterals are many and include azygous, hemiazygous, vertebral venous plexus, internal mammary veins, intercostal veins, lateral thoracic system
    - Common etiologies are lung cancer, metastases (like breast cancer), lymphoma, fibrosing mediastinitis, radiation change
  • Persistent Left SVC: Facts
    - Represents persistence of the left common cardinal vein
    - Usually drains into the coronary sinus
    - Usually associated with absent left brachiocephalic vein
    - Usually has SVC present as well
    - Occurs in 0.2-0.4% of patients
  • “ Multidetector CT is an alternative tool helpful in establishing the primary diagnosis, defining anatomic landmarks and their relationships, and identifying associated cardiovascular anomalies. It is also an adjunct in the evaluation of complications during follow-up.”
    Uncommon Congenital and Acquired Aortic Disease: Role of Multidetector CT Angiography
    Kimura-Hayama ET, et al
    RadioGraphics 2010; 30;79-98
  • “ With its high spatial resolution and isotropic and volumetric information multidetector CT performed with or without ECG-gated technique allows accurate and fast noninvasive characterization of aortic pathologic conditions.”
    Uncommon Congenital and Acquired Aortic Disease: Role of Multidetector CT Angiography
    Kimura-Hayama ET, et al
    RadioGraphics 2010; 30;79-98
  • Patent Ductus Arteriosus: Facts
    - Connects the proximal descending aorta, immediately distal to the origin of the left subclavian artery, with the proximal left pulmonary artery at the junction of the main pulmonary artery
    - Closes functionally 18-24 hours after birth and anatomically at one month
    - If it is patent after 3 months it is a PDA
  • Patent Ductus Arteriosus: Facts
    - PDA occurs in 1 of 2,000 children born full term
    - More common in woman (2-1)
    - Treatment includes surgical closure or percutaneous placement of an occluder devise
  • Persistent Left SVC: Facts
    - Represents persistence of the left common cardinal vein
    - Usually drains into the coronary sinus
    - Usually associated with absent left brachiocephalic vein
    - Usually has SVC present as well
    - Occurs in 0.2-0.4% of patients
  • “ Multidetector CT is an alternative tool helpful in establishing the primary diagnosis, defining anatomic landmarks and their relationships, and identifying associated cardiovascular anomalies. It is also an adjunct in the evaluation of complications during follow-up.”
    Uncommon Congenital and Acquired Aortic Disease: Role of Multidetector CT Angiography
    Kimura-Hayama ET, et al
    RadioGraphics 2010; 30;79-98
  • “ With its high spatial resolution and isotropic and volumetric information multidetector CT performed with or without ECG-gated technique allows accurate and fast noninvasive characterization of aortic pathologic conditions.”
    Uncommon Congenital and Acquired Aortic Disease: Role of Multidetector CT Angiography
    Kimura-Hayama ET, et al
    RadioGraphics 2010; 30;79-98
  • Patent Ductus Arteriosus: Facts
    - Connects the proximal descending aorta, immediately distal to the origin of the left subclavian artery, with the proximal left pulmonary artery at the junction of the main pulmonary artery
    - Closes functionally 18-24 hours after birth and anatomically at one month
    - If it is patent after 3 months it is a PDA
  • Patent Ductus Arteriosus: Facts
    - PDA occurs in 1 of 2,000 children born full term
    - More common in woman (2-1)
    - Treatment includes surgical closure or percutaneous placement of an occluder devise

Privacy Policy

Copyright © 2024 The Johns Hopkins University, The Johns Hopkins Hospital, and The Johns Hopkins Health System Corporation. All rights reserved.